Inhaled nitric oxide aggravates phosgene model of acute lung injury

Inhalation Toxicology

Volumn 23, Issue 13, 2011, Pages 842-852

  Li, Wen Li ^a   Hai, Chun Xu ^a   Pauluhn, Jürgen ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b BAYER PHARMA AG   (Germany)

Author keywords

Countermeasures; Irritation; Lung function; Mode of action; Nitric oxide; Oxidative stress; Phosgene; Pulmonary toxicity

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSGENE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSIMETRY; EXPOSURE; LATENT PERIOD; LUNG FUNCTION; LUNG LAVAGE; LYMPHATIC DRAINAGE; MALE; NONCARDIOGENIC LUNG EDEMA; NONHUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; ENZYME INHIBITORS; IRRITANTS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSGENE; PLETHYSMOGRAPHY, WHOLE BODY; PROTEINS; PYRUVATES; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RODENTIA;

EID: 80155192396     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2011.618849     Document Type: Article

References (56)

1. AEGL. 2002. (Acute Exposure Guideline Levels) for Selected Airborne Chemicals, Volume 2. Phosgene. Prepared by the National Research Council of the National Academies. The National Academies Press, Washington D.C. U.S. pp. 15-70
2. Allison RC. 1991. Initial treatment of pulmonary edema: a physiological approach. Am J Med Sci 302:385-391
3. Baekey DM, Molkov YI, Paton JF, Rybak IA, Dick TE. 2010. Effect of baroreceptor stimulation on the respiratory pattern: insights into respiratory-sympathetic interactions. Respir Physiol Neurobiol 174:135-145
4. Barnes PJ, Belvisi MG. 1993. Nitric oxide and lung disease. Thorax 48:1034-1043 (Pubitemid 23319631)
5. Berthiaume Y. 1998. Mechanisms of edema clearance. In: Pulmonary Edema, Weir E.K
6. Berthiaume Y, Lesur O, Dagenais A. 1999. Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium. Thorax 54:150-160 (Pubitemid 29101361)
7. Berthiaume Y, Folkesson HG, Matthay MA. 2002. Lung edema clearance: 20 years of progress: invited review: alveolar edema fluid clearance in the injured lung. J Appl Physiol 93:2207-2213 (Pubitemid 35379349)
8. Berthiaume Y, Matthay MA. 2007. Alveolar edema fluid clearance and acute lung injury. Respir Physiol Neurobiol 159:350-359 (Pubitemid 350123611)
9. Borak J, Diller WF. 2001. Phosgene exposure: mechanisms of injury and treatment strategies. J Occup Environ Med 43:110-119 (Pubitemid 32175109)
10. Chen HI. 1995. Hemodynamic mechanisms of neurogenic pulmonary edema. Biol Signals 4:186-192 (Pubitemid 26008691)
11. Chen HL, Bai H, Xi MM, Liu R, Qin XJ, Liang X, Zhang W, Zhang XD, Li WL, Hai CX. 2011. Ethyl pyruvate protects rats from phosgeneinduced pulmonary edema by inhibiting cyclooxygenase2 and inducible nitric oxide synthase expression. J Appl Toxicol. Doi: 10.1002/jat.1713
12. Chen HL, Hai CX, Liang X, Zhang XD, Liu R, Qin XJ. 2009. Correlation between sPLA2-IIA and phosgene-induced rat acute lung injury. Inhal Toxicol 21:374-380
13. Creagh-Brown BC, Griffiths MJ, Evans TW. 2009. Bench-to-bedside review: Inhaled nitric oxide therapy in adults. Crit Care 13:221
14. Diller WF. 1980. The methenamine misunderstanding in the therapy of phosgene poisoning. Arch Toxicol 46:199-206 (Pubitemid 11203796)
15. Directive 86/609/EEC 1986. Guideline of the Council dated November 24, 1986 on the Reconciliation of Legal and Administrative Regulations of the Member Countries for the Protection of Animals used for Studies and other Scientific Purposes. Journal of the European Community, Legal Specifications L358, 29, pp. 1-28
16. Duniho SM, Martin J, Forster JS, Cascio MB, Moran TS, Carpin LB, Sciuto AM. 2002. Acute changes in lung histopathology and bronchoalveolar lavage parameters in mice exposed to the choking agent gas phosgene. Toxicol Pathol 30:339-349 (Pubitemid 34556105)
17. Evans MJ. 1982. Cell death and cell renewal in small airways and alveoli. In: H. Witschi and P. Nettesheim (eds). Mechanisms in Respiratory. Toxicology, vol. I, CRC Press Inc., Boca Raton, Florida, pp. 189-218
18. Grainge C, Rice P. 2010. Management of phosgene-induced acute lung injury. Clin Toxicol (Phila) 48:497-508
19. Hinder F, Booke M, Traber LD, Traber DL. 1997. Nitric oxide and endothelial permeability. J Appl Physiol 83:1941-1946 (Pubitemid 28006494)
20. Ivanhoe F, Meyers FH. 1964. Phosgene Poisoning as an Example of Neuroparalytic Acute Pulmonary Edema: The Sympathetic Vasomotor Reflex Involved. Dis Chest 46:211-218
21. Ji L, Liu R, Zhang XD, Chen HL, Bai H, Wang X, Zhao HL, Liang X, Hai CX. 2010. N-acetylcysteine attenuates phosgene-induced acute lung injury via up-regulation of Nrf2 expression. Inhal Toxicol 22:535-542
22. Kang JL, Park W, Pack IS, Lee HS, Kim MJ, Lim CM, Koh Y. 2002. Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation. J Appl Physiol 92:795-801 (Pubitemid 34671050)
23. Kao KK, Fink MP. 2010. The biochemical basis for the antiinflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem Pharmacol 80:151-159
24. Kluge S, Szinicz L. 2005. Appendix: acute exposure guideline levels (AEGLs) toxicity and properties of selected chemical and biological agents. Toxicology 214:268-270
25. Kristof AS, Goldberg P, Laubach V, Hussain SN. 1998. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 158:1883-1889 (Pubitemid 29008829)
26. Kung CW, Lee YM, Cheng PY, Peng YJ, Yen MH. 2011. Ethyl pyruvate reduces acute lung injury via regulation of iNOS and HO-1 expression in endotoxemic rats. J Surg Res 167:e323-e331
27. Lailey AF, Hill L, Lawston IW, Stanton D, Upshall DG. 1991. Protection by cysteine esters against chemically induced pulmonary oedema. Biochem Pharmacol 42 Suppl:S47-S54
28. Layne. 1957. Total protein-modified according to Layne E. Spectrophotometric and Turbidimetric Methods for Measuring Proteins, II. Protein Estimation with the Folin-Ciocalteu Reagent. Methods in Enzymology 3:447-454
29. Li WL, Hai CX, Liang X, Zhang XD, Chen HL, Qin XJ, Liu R, He W, Wang P, Li B. 2006. Apoptosis of ATII cells in mice induced by phosgene. Inhal Toxicol 18:71-77 (Pubitemid 41770219)
30. Li WL, Pauluhn J. 2010. Comparative assessment of the sensory irritation potency in mice and rats nose-only exposed to ammonia in dry and humidified atmospheres. Toxicology 276: 135-142
31. Matthay MA, Clerici C, Saumon G. 2002. Invited review: Active fluid clearance from the distal air spaces of the lung. J Appl Physiol 93:1533-1541
32. Matthay MA, Folkesson HG, Clerici C. 2002. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 82:569-600 (Pubitemid 34743332)
33. McMullan S, Dick TE, Farnham MM, Pilowsky PM. 2009. Effects of baroreceptor activation on respiratory variability in rat. Respir Physiol Neurobiol 166:80-86
34. OECD 2009. Organization for Economic Cooperation and Development (OECD) -Environment, Health and Safety Publications, Series on Testing and Assessment No. 39: Guidance Document for Acute Inhalation Toxicity Testing, [ENV/JM/MONO 28; July 21, 2009] Available at: http://oberon.sourceoecd.org.
35. OECD 2009. Organization for Economic Cooperation and Development (OECD) -Environment, Health and Safety Publications, Series on Testing and Assessment No. 39: Guidance Document for Acute Inhalation Toxicity Testing, [ENV/JM/MONO 28; July 21, 2009] Available at: http://oberon.sourceoecd.org.
36. Paintal AS. 1969. Mechanism of stimulation of type J pulmonary receptors. J Physiol (Lond) 203:511-532
37. Paintal AS. 1981. Effects of drugs on chemoreceptors, pulmonary and cardiovascular receptors in Widdicombe JG (ed). International encyclopedia of pharmacology and therapeutics, Section 104, respiratory pharmacology. Pergamon Press, Oxford, pp. 217-239
38. Parker JC, Parker RE, Granger DN, Taylor AE. 1981. Vascular permeability and transvascular fluid and protein transport in the dog lung. Circ Res 48:549-561 (Pubitemid 11150958)
39. Pauluhn J. 2004. Comparative analysis of pulmonary irritation by measurements of Penh and protein in bronchoalveolar lavage fluid in brown Norway rats and Wistar rats exposed to irritant aerosols. Inhal Toxicol 16:159-175 (Pubitemid 38372560)
40. Pauluhn J. 2006a. Acute nose-only exposure of rats to phosgene. Part I: concentration x time dependence of LC50s, nonlethal-threshold concentrations, and analysis of breathing patterns. Inhal Toxicol 18:423-435
41. Pauluhn J. 2006b. Acute nose-only exposure of rats to phosgene. Part II. Concentration x time dependence of changes in bronchoalveolar lavage during a follow-up period of 3 months. Inhal Toxicol 18:595-607 (Pubitemid 44178416)
42. Pauluhn J, Thiel A. 2007. A simple approach to validation of directedflow nose-only inhalation chambers. J Appl Toxicol 27:160-167 (Pubitemid 46480583)
43. Pauluhn J, Carson A, Costa DL, Gordon T, Kodavanti U, Last JA, Matthay MA, Pinkerton KE, Sciuto AM. 2007. Workshop summary: phosgene-induced pulmonary toxicity revisited: appraisal of early and late markers of pulmonary injury from animal models with emphasis on human significance. Inhal Toxicol 19:789-810 (Pubitemid 47237752)
44. Pauluhn J, Hai CX. 2011. Attempts to counteract phosgene-induced acute lung injury by instant high-dose aerosol exposure to hexamethylenetetramine, cysteine or glutathione. Inhal Toxicol 23:58-64
45. Persson CG, Erjefalt JS, Andersson M, Greiff L, Svensson C. 1996. Extravasation, lamina propria flooding and lumenal entry of bulk plasma exudate in mucosal defence, inflammation and repair. Pulm Pharmacol 9:129-139 (Pubitemid 26401815)
46. Proudfoot AG, McAuley DF, Griffiths MJ, Hind M. 2011. Human models of acute lung injury. Dis Model Mech 4:145-153
47. Radi R, Beckman JS, Bush KM, Freeman BA. 1991. Peroxynitriteinduced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288:481-487
48. Sarnoff SJ, Berglund E, Sarnoff LC. 1953. Neurohemodynamics of pulmonary edema. III. Estimated changes in pulmonary blood volume accompanying systemic vasoconstriction and vasodilation. J Appl Physiol 5:367-374
49. Sciuto AM, Strickland PT, Kennedy TP, Gurtner GH. 1995. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am J Respir Crit Care Med 151:768-772
50. Sciuto AM. 1997. Ibuprofen treatment enhances the survival of mice following exposure to phosgene. Inhal Toxicol 9:389-403 (Pubitemid 27218793)
51. Sciuto AM, Hurt HH. 2004. Therapeutic treatments of phosgeneinduced lung injury. Inhal Toxicol 16:565-580 (Pubitemid 38923919)
52. Sedy J, Zicha J, Kunes J, Hejcl A, Sykova E. 2009. The role of nitric oxide in the development of neurogenic pulmonary edema in spina cord-injured rats: the effect of preventive interventions. Am J Physiol Regul Integr Comp Physiol 297:R1111-R1117
53. Smart JK. 1997. History of chemical and biological warfare: an American perspective. In: Sidell, F.R., Takafuji, E.T., Franz, D.R. (Eds). Medical Aspects of Chemical and Biological Warfare. Borden Institute, Walter Reed Army Medical Center, Washington DC
54. Szinicz L. 2005. History of chemical and biological warfare agents. Toxicology 214:167-181 (Pubitemid 41406257)
55. Wizemann TM, Gardner CR, Laskin JD, Quinones S, Durham SK, Goller NL, Ohnishi ST, Laskin DL. 1994. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J Leukoc Biol 56:759-768
56. Zhang XD, Hou JF, Qin XJ, Li WL, Chen HL, Liu R, Liang X, Hai CX. 2010. Pentoxifylline inhibits intercellular adhesion molecule-1 (ICAM-1) and lung injury in experimental phosgene-exposure rats. Inhal Toxicol 22:889-895